4//SEC Filing
Bukofzer Stan 4
Accession 0001005201-19-000058
CIK 0001005201other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:56 PM ET
Size
8.8 KB
Accession
0001005201-19-000058
Insider Transaction Report
Form 4
Bukofzer Stan
Chief Medical Officer & SVP***
Transactions
- Tax Payment
Common Stock
2019-04-02$5.16/sh−7,434$38,359→ 22,936 total - Exercise/Conversion
Common Stock
2019-04-02+25,370→ 30,370 total - Exercise/Conversion
Restricted Stock Units
2019-04-02−25,370→ 65,954 totalExp: 2021-04-02→ Common Stock (25,370 underlying)
Footnotes (4)
- [F1]Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.
- [F3]These Restricted Stock Units are scheduled to vest 27.78% on April 2, 2019, 27.78% on April 2, 2020 and 44.44% on April 2, 2021.
- [F4]The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
Documents
Issuer
Assertio Therapeutics, Inc
CIK 0001005201
Entity typeother
Related Parties
1- filerCIK 0001663041
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:56 PM ET
- Size
- 8.8 KB